Search results for: result

Need a new search?

If you didn't find what you were looking for, try a new search!

Decline of an Invention: A Broken Patent System

By |2017-09-08T12:46:10+05:30March 4th, 2017|Patent|

The cost of dozens of brand-name drugs have nearly doubled in just the past five years. Public outrage over drug prices extends from Capitol Hill to the presidential candidates to patients. In response, pharmaceutical executives are spending more on lobbying and marketing. Yet for all this attention, most of the proposed solutions for reducing [...]

New MedsPal Database: Enhancing Transparency in the Patent Field

By |2017-09-08T12:49:16+05:30March 3rd, 2017|Patent|

A new database was launched this week to facilitate navigation through the patent field and increase transparency surrounding the patent status of medicines and licenses. The Medicines Patent Pool (MPP), Chile’s National Institute of Industrial Property (INAPI), and global health initiative UNITAID held a side event at the WIPO General Assemblies on 5 October. [...]

R&D’S LATEST FIGURES FOR NEGLECTED DISEASE

By |2017-09-08T12:49:49+05:30March 3rd, 2017|International, Patent|

Recently due to Ebola outbreak, the financing for research and development into so called neglected diseases rose recently,which usually affecting the lower-income population and private sector contribution score the biggest share according to the available data from the Gates-Foundation supported database. Methodology Survey design therefore focused on two elements. The first was disease, product, [...]

Streak of enlightenment: “Vaccine for common-cold”

By |2017-09-08T12:52:44+05:30January 12th, 2017|Innovation, International, Patent|

Humans have been chasing a cure for the common cold, but it’s seemed to be entirely out of our grasp, it’s become modern medicine's version of pigs flying. But now there seems a streak of transformation and enlightenment in this darkness which has prevailed from decades. A scientist has registered a patent for a [...]

World’s 1st low-GI sugar by “Holista CollTech”

By |2017-09-08T12:54:47+05:30January 6th, 2017|Innovation, International, Patent|

In a release to the ASX this morning Holista, which has offices in Perth and Kuala Lumpur, said it was working with Florida based 2017 Noble Prize nominee Daryl Thompson on the ingredient. Holista CollTech, a Perth-based biotech, to file a patent for the world’s first low-GI sugar made out of all-natural ingredients. Holista, [...]

Sanofi, Regeneron lose bid to overturn Amgen

By |2017-09-08T12:56:35+05:30January 5th, 2017|International, Patent|

Sanofi (NYSE:SNY) and Regeneron Pharmaceuticals (NASDAQ:REGN) lose their bid to overturn a court verdict upholding two Amgen (NASDAQ:AMGN) patents covering cholesterol drug Repatha (evolocumab). Amgen sued the companies in August 2014 in an attempt to prevent them from selling rival drug Praluent (alirocumab). Both of them lower cholesterol by blocking a protein called PCSK9. [...]

A happy ending to trademark : secondshaadi.com

By |2017-09-08T13:04:42+05:30January 4th, 2017|India, Trademark|

Wise old saying -“There is always a second chance” was followed by www.secondshaadi.com. This domain name was launched by Vivek Pahwa and others (herein referred as ‘Defendants’) on January 25, 2006. It was cater to those seeking to marry again; hence the name, making the market position of the website completely different. On the [...]

All Patents related to Plants and Animals kept on Hold

By |2017-09-08T13:06:17+05:30January 4th, 2017|International, Patent|

Frustrating news for the biotech industry, the European Patent Office (EPO) has decided to suspend all examination and opposition proceedings for patents concerning plants/animals that are obtained by means of essentially biological processes.  This follows a recent non-binding Notice from the European Commission (EC) regarding the interpretation of certain aspects of Directive 98/44/EC (the [...]

Is Copyright Law overriding Section 79 of the IT Act?

By |2017-09-08T13:08:27+05:30January 4th, 2017|Copyright, India|

The proviso to Section 81 override the “safe harbour” granted to intermediaries under Section 79 of the IT Act Section 81 which state that the provision of the act shall have an overriding effect. The provision states that nothing contained in this Act shall restrict any person from exercising any right conferred under the Copyright [...]

Go to Top